Is testosterone replacement therapy in males with hypogonadism cost-effective? An analysis in Sweden

Testosterone replacement therapy (TRT) has been recommended for the treatment of primary and secondary hypogonadism. However, long-term implications of TRT have not been investigated extensively. The aim of this analysis was to evaluate health outcomes and costs associated with life-long TRT in pati...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Journal of sexual medicine Ročník 11; číslo 1; s. 262
Hlavní autoři:	Arver, Stefan, Luong, Ba, Fraschke, Anina, Ghatnekar, Ola, Stanisic, Sanja, Gultyev, Dmitry, Müller, Elvira
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Netherlands 01.01.2014
Témata:	Cardiovascular Diseases - chemically induced Cerebrovascular Disorders - chemically induced Cost-Benefit Analysis Depression - chemically induced Diabetes Mellitus, Type 2 - chemically induced Hormone Replacement Therapy - adverse effects Hormone Replacement Therapy - economics Humans Hypogonadism - drug therapy Klinefelter Syndrome - drug therapy Male Outcome Assessment (Health Care) Quality-Adjusted Life Years Sweden Testosterone - adverse effects Testosterone - economics Testosterone - therapeutic use Sweden Testosterone Replacement Therapy Cost-Effectiveness Long-Term Implications Hypogonadism
ISSN:	1743-6109, 1743-6109
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!